Hemoglobin disorders newborn screening comment-discussion

ChemistryAlso known as: Hemoglobin disorders NBS commentN/A

Screens newborn blood for genetic hemoglobin disorders including sickle cell disease.

Normal Range
Consult your provider
N/A
Abnormal Levels
Consult your provider
Specimen Type
Blood

Why This Biomarker Matters

Early detection of hemoglobin disorders enables immediate treatment and preventive care. Allows families to avoid serious complications and plan appropriate medical management from birth.

Overview

This test involves newborn screening for hemoglobin disorders—genetic conditions affecting red blood cell function, such as sickle cell disease and thalassemia. Blood is collected from a newborn heel prick on a filter card. Early detection allows for immediate treatment and management, preventing serious complications like pain crises, organ damage, and death. Most U.S. states include hemoglobin screening in routine newborn panels. Results include interpretive comments guiding follow-up testing and pediatric care.

Technical Information (LOINC Codes)

Standardized laboratory codes for this biomarker

57703-1Primary
Hemoglobin disorders newborn screening comment-discussion